LOINC
Version 2.70

97184-6Ravulizumab [Mass/volume] in SerumActive

Part Description

LP422971-4   Ravulizumab
Ravulizumab is a complement C5 inhibitor that is used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Its mechanism of action is binding to the C5 protein, which prevents formation of the complement C5b-9 complex. [PMID: 30767127] Source: Regenstrief LOINC

Fully-Specified Name

Component
Ravulizumab
Property
MCnc
Time
Pt
System
Ser
Scale
Qn
Method

Additional Names

Short Name
Ravulizumab Ser-mCnc
Display Name
Ravulizumab (S) [Mass/Vol]
Consumer Name Alpha
Ravulizumab, Blood

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.70
Last Updated
Version 2.70
Order vs. Observation
Both

Example Units

Unit Source
ug/mL Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=97184-6